Genomics transforms how we understand ourselves and the world around us. Our research fuels innovative ways to study, diagnose, and treat disease. It paves the way to aggregate data, analyze it, and interpret it for meaningful insights. See the latest here:
Recent Articles
Featured Publications
- Chen, X, et al. Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data. Genetics in Medicine. 2020;22(5):945-953.
- Dolzhenko, E, et al. ExpansionHunter Denovo: A computational method for locating known and novel repeat expansions in short-read sequencing data. Genome Biology. 2020;21(1):102.
- Dolzhenko, E, et al. Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome Research. 2017;27(11):1895-1903.
- Jaganathan, K, et. al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176(3):535-548.
- Sundaram, Lakshmi at. al. Predicting the clinical impact of human mutation with deep neural networks. Nat Genet. 2018;50(8):1161-1170.
- Chen, X, et al. Cyrius: accurate CYP2D6 genotyping using whole genome sequencing data. biorXiv. 2020.
Multimedia Highlights
Podcasts
Listen as leading scientists discuss the impact of genomics and hear directly from the people whose work is shaping discovery.
iCommunity
Access in-the-field research news, customer experiences, and the latest in product developments.
Customer Videos
Gain insight by watching webinars, scientific reviews, product introductions, and more.
Upcoming Events
In the News
| Date | Publication | Title |
|---|---|---|
| 10-May-2021 | San Diego Business Journal | Industry Looks at Ways to Sustain Growth After Pandemic |
| 30-Apr-2021 | Medtech Dive | Illumina sues European Commission to block competition probe into Grail buyout |
| 30-Apr-2021 | Socal Tech | Illumina Donates $60M To Pathogen Genomics Effort |
| 29-Apr-2021 | GenomeWeb | Illumina Challenges European Commission's Jurisdiction Over Review of Grail Acquisition in EU General Court |
| 29-Apr-2021 | Fierce Biotech | Illumina sues European Commission to stop investigation of $8B Grail acquisition |
Careers at Illumina
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for Jobs